The NCI and the Takeoff of Nanomedicine
This paper presents an analysis of the role of US National Nanotechnology Initiative's Federal funding in the takeoff of nanobiotechnology and nanomedicine. Our comparative analysis of leading nanobiotechnology and nanomedicine scientists funded by the National Cancer Institute highlights the p...
Saved in:
Published in | Journal of Nanomedicine & Biotherapeutic Discovery Vol. 5; no. 3; p. 1 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
2015
|
Online Access | Get full text |
Cover
Loading…
Abstract | This paper presents an analysis of the role of US National Nanotechnology Initiative's Federal funding in the takeoff of nanobiotechnology and nanomedicine. Our comparative analysis of leading nanobiotechnology and nanomedicine scientists funded by the National Cancer Institute highlights the programmatic efforts of the NCI's Alliance for Nanotechnology in Cancer beginning in 2005. We use a data science approach combining web data extraction, bibliometrics and social network analysis to identify leading nanomedicine and nanobiotechnology scientists and profile their research and commercialization efforts. By coupling leading nanomedicine researchers profiles to NNI Federal funding data we discover and document the relative importance of the US National Cancer Institute's Alliance for Nanotechnology in Cancer (NCI Alliance) to the takeoff of nanomedicine. The NCI appears to be achieving its stated goal of contributing to both the scientific and commercial infrastructure of translational nanomedicine. Using Gilsing et al.'s innovation network embeddedness model from 2008 we find that the creation and strategic placement of NCI Alliance Centers at critical positions in the Alliance network has enhanced the ability of the NCI to build a sustainable architecture for nanomedicine and foster potentially disruptive pioneering innovation. |
---|---|
AbstractList | This paper presents an analysis of the role of US National Nanotechnology Initiative's Federal funding in the takeoff of nanobiotechnology and nanomedicine. Our comparative analysis of leading nanobiotechnology and nanomedicine scientists funded by the National Cancer Institute highlights the programmatic efforts of the NCI's Alliance for Nanotechnology in Cancer beginning in 2005. We use a data science approach combining web data extraction, bibliometrics and social network analysis to identify leading nanomedicine and nanobiotechnology scientists and profile their research and commercialization efforts. By coupling leading nanomedicine researchers profiles to NNI Federal funding data we discover and document the relative importance of the US National Cancer Institute's Alliance for Nanotechnology in Cancer (NCI Alliance) to the takeoff of nanomedicine. The NCI appears to be achieving its stated goal of contributing to both the scientific and commercial infrastructure of translational nanomedicine. Using Gilsing et al.'s innovation network embeddedness model from 2008 we find that the creation and strategic placement of NCI Alliance Centers at critical positions in the Alliance network has enhanced the ability of the NCI to build a sustainable architecture for nanomedicine and foster potentially disruptive pioneering innovation. |
Author | Patrick Herron, Tim Lenoir |
Author_xml | – sequence: 1 givenname: Tim Lenoir surname: Patrick Herron fullname: Patrick Herron, Tim Lenoir |
BookMark | eNpNkE9Lw0AQxRepYK39AN5y00vq7P_NUYLWQqmXHLwtm80sBtNszbYHv70JLeJhmMfjzcDv3ZJZH3sk5J7CSlDNnhiVMi8M_1hRAKBcXpH5nzf7p2_IMqW2BpBSGSPVnDxUn5jtyk3m-iY7jrpyXxhDyGLIdq6Pe2xa3_Z4R66D6xIuL3tBqteXqnzLt-_rTfm8zb2WkBcNGCZ0g5xBXRSKSzRBNdKg5JopJoRU0OgaA9e1cALHA8pkAONBKe_4gjye3x6G-H3CdLT7NnnsOtdjPCU70rJpDIxReo76IaY0YLCHod274cdSsFMtdsK2E7a91MJ_ASEcU38 |
ContentType | Journal Article |
DBID | AAYXX CITATION 7QO 8FD FR3 P64 |
DOI | 10.4172/2155-983X.1000135 |
DatabaseName | CrossRef Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitle | CrossRef Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | Engineering Research Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2155-983X |
EndPage | 1 |
ExternalDocumentID | 10_4172_2155_983X_1000135 |
GroupedDBID | AAYXX ALMA_UNASSIGNED_HOLDINGS CITATION KQ8 7QO 8FD FR3 P64 |
ID | FETCH-LOGICAL-c750-9d08247de320b99635e8f6d58e53726244560d7bef37b4a4e9d0125f08c066ca3 |
ISSN | 2155-983X |
IngestDate | Fri Apr 12 07:05:50 EDT 2024 Fri Aug 23 01:53:18 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c750-9d08247de320b99635e8f6d58e53726244560d7bef37b4a4e9d0125f08c066ca3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PQID | 1722172280 |
PQPubID | 23462 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_1722172280 crossref_primary_10_4172_2155_983X_1000135 |
PublicationCentury | 2000 |
PublicationDate | 2015-00-00 20150101 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – year: 2015 text: 2015-00-00 |
PublicationDecade | 2010 |
PublicationTitle | Journal of Nanomedicine & Biotherapeutic Discovery |
PublicationYear | 2015 |
SSID | ssib005568856 ssib027512736 |
Score | 1.9474438 |
Snippet | This paper presents an analysis of the role of US National Nanotechnology Initiative's Federal funding in the takeoff of nanobiotechnology and nanomedicine.... |
SourceID | proquest crossref |
SourceType | Aggregation Database |
StartPage | 1 |
Title | The NCI and the Takeoff of Nanomedicine |
URI | https://search.proquest.com/docview/1722172280 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1dS8MwFA06X3wRRcX5RQVBUKq1adrsUYcyRQdChb2VpE1gDFqZ24u_3pN-rXMTnC-lhOSS5qS5J7m59xJyzgTT6GBigywHtickfikmpe1oRXViYkwJ4-_82vd7797zgA1m2d5y75KJvI6_lvqV_AdVlAFX4yW7ArK1UBTgHfjiCYTx_DPG_e5TfQsyFCOVaZ2fAog0m7ObLxLQZpV8BtwPm-5YJjBnbC541ofuRTj_EVTVeFwY64H01YtKs-G4eXpQeE4Wywt0PbM7PM_GC02wpKxcH1ljGtBlq64HEmQcS6rG5uYFmCWbqZjKrP5D89T3AbETMUIiIyIyIqJSxDrZyCMcGmv7WyPuGPM5nwUBcgPQliBPB1l3orBgG6k3Cx2b5yDzKjjnFeE22SrxsO4KdHfImkp3yQWQtYCsBWQtYGKVyFqZtpqw7ZHw8SHs9uwypYUdg5rZnQSMywsSRV1HYqdJmeLaTxhXjAauD6oFApoEUmkaSE94Cg3AQLXDY1DDWNB90kqzVB0QK8bG37t1uBId6gmlZcJZ7CYmnqF0XeG3yWX1jdFHEbgk-nWY2-SsGoUIy4uxGYlUZdPPCNVNCjOXO4erCDwim2a2FWdVx6Q1GU_VCdjbRJ7mSH4Dt9U7TA |
link.rule.ids | 314,780,784,4024,27923,27924,27925 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+NCI+and+the+Takeoff+of+Nanomedicine&rft.jtitle=Journal+of+Nanomedicine+%26+Biotherapeutic+Discovery&rft.au=Patrick+Herron%2C+Tim+Lenoir&rft.date=2015&rft.issn=2155-983X&rft.eissn=2155-983X&rft.volume=5&rft.issue=3&rft_id=info:doi/10.4172%2F2155-983X.1000135&rft.externalDBID=n%2Fa&rft.externalDocID=10_4172_2155_983X_1000135 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2155-983X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2155-983X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2155-983X&client=summon |